SavedAdd your journal

Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2013 / Cilt: 23 - Sayı: 2

Evaluatıon of hospıtalızed herpes zoster cases

Hastaneye yatırılan herpes zoster olgularının değerlendirilmesi

ŞÜKRAN KÖSE
Sabri ATALAY
Selma GÜL
Ufuk SÖNMEZ
İlker ÖDEMİŞ
Pages
89–92
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Cases in high risk groups should be vaccinated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To evaluate hospitalized cases of herpes zoster in respect of demographic data, risk factors and complications.
📊
Key Findings & Data:Material and Method: In this study, herpes zoster cases who admitted between November 2007 and April 2013 were assessed for demographic data such as age and gender, risk factors, clinical course and complications.
💡
Conclusion & Impact:Cases in high risk groups should be vaccinated.
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: To evaluate hospitalized cases of herpes zoster in respect of demographic data, risk factors and complications. Material and Method: In this study, herpes zoster cases who admitted between November 2007 and April 2013 were assessed for demographic data such as age and gender, risk factors, clinical course and complications. Herpes zoster was clinically diagnosed. Findings: Twenty three patients were included in the study. 17 (73.91%) patients were male, the mean age was 64.08 years.(22-90). Twelve(52.18%) of them were 65 years or older. The most frequent risk factor was diabetes mellitus and the most frequent complication was bacterial superinfection. Conclusions: Early diagnosis and treatment of herpes zoster is important especially in diabetic and elderly patients due to high morbidity. Cases in high risk groups should be vaccinated.

Özet

Amaç: Hastanede yatarak izlenen Herpes Zoster olgularını demografik veriler, risk faktörleri ve komplikasyonlar açısından değerlendirmek. Gereç ve Yöntem: Çalışmada 2007 Kasım-2013 Nisan tarihleri arasında klinik olarak Herpes Zoster tanısı konan ve yatarak tedavi gören olguların verileri geriye dönük incelenmiştir. Bulgular: Çalışmaya 23 hasta alınmıştır. 17’si (%73.91) erkek, yaş ortalaması 64.08 (22- 90). Hastaların 12’si (%52.18) 65 yaş ve üzerinde olan hastalardır. En sık rastlanan risk faktörü diabetes mellitus, en sık komplikasyon bakteriyel süperinfeksiyon olarak saptanmıştır. Sonuç: Herpes zosterin erken tanı ve tedavisi yüksek morbiditesinden dolayı özellikle diyabetik ve yaşlı hastalarda önemlidir. Yüksek risk grubundaki olgular aşılanmalıdır.

🔖

Cite This Article

KÖSE, Ş., ATALAY, S., GÜL, S., SÖNMEZ, U., ÖDEMİŞ, İ. (2013). Evaluatıon of hospıtalızed herpes zoster cases. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 23 - Sayı: 2, 89–92. https://ajindex.com/articles/268388

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Gnann JW Jr, Whitley RJ. Clinical practice: herpes zoster. NEJM 2002; 347:340-6. Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001; 32: 1481-6.
  2. Yaszay B, Jablecki CK, Safran MR. Zoster paresis of the shoulder. Case report and review of the literature. Clin Orthop 2000; 377: 112-8. Whitley R J. Varicella Zoster Virus. In: Mandell G L, Bennet J E, Dolin R(ed). Douglas and Bennett’s Principles and Practice of Infectious Diseases. Mandell, Sixth Ed.Vol. 2 Elsevier Churchill Livingstone, 2005: 1780-6.
  3. Kumbasar B, Yenigun M, Ataoglu HE, Sar F, Serez K, Turker T, et al. The prevalence of metabolic syndrome in different groups in Turkey. J Int Med Res. 2013 Feb; 41(1):188-99. Arvin A. Aging, immunity and the varicella zoster virus. NEJM.2005; 352: 2266-7.
  4. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for hepes zoster? Lancet Infect Dis.2004; 4: 26-33. Schmader K. Herpes zoster and postherpetic nevralgia in older adults. Clin Geriatr Med. 2007; 23(3): 615-32.
  5. Yawn BP, Wollan PC, Kurland MJ, ST Sauver JL, Saddier P. Herpes zoster reccurrences more frequent than previously eported. Mayo Clin Proc. 2011 Feb; 86(2): 88-93.
  6. Masci G, Magagnoli M, Gullo G, Morenghi E, Gaeassino I, Simonelli M, et al. Herpes infections in breast cancer patients reated with adjuant chemotherapy.Oncology.2006;71:164-7.
  7. Opstelten W, Van Essen GA, Schellevis F, Verheji TJ, Moons KG. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol. 2006; 16: 692-5.
  8. Morgan D, Mahe C, Malamba S, Okongo M, Mayanja B,Whitworth J. Herpes zoster and HIV-1 infection in a rural Ugandan cohort. AIDS. 2001;15:223-9. Kahl LE. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome. J Rheumatol. 1994; 21: 84-6.
  9. Wolfe F, Michaud K, Chakravarty EF. Rates and predictors of herpes zoster in patients with arthritis and noninflamatory musculoskeletal disorders. Rheumatology(Oxford). 2006; 45:1431-8.
  10. Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, et al. The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum. 2007 Dec 15;57(8):1431-8.
  11. Donahue JG, Choo PW, Manson JE, Platt R. The incidence of herpes zoster. Arch Intern Med. 1995; 155:1605-9.
  12. Peleg AY, Weerarathna T, McCarthy JS, Davis TM. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 2007; 23: 3-13. Cal